First Business Financial Services Inc. Has $3.56 Million Holdings in Stryker Corporation (NYSE:SYK)

First Business Financial Services Inc. lifted its holdings in Stryker Corporation (NYSE:SYK - Free Report) by 7.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,550 shares of the medical technology company's stock after buying an additional 645 shares during the quarter. Stryker accounts for 0.3% of First Business Financial Services Inc.'s portfolio, making the stock its 29th biggest holding. First Business Financial Services Inc.'s holdings in Stryker were worth $3,555,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Capital A Wealth Management LLC purchased a new position in shares of Stryker during the 4th quarter worth approximately $26,000. Goodman Advisory Group LLC acquired a new stake in Stryker during the 1st quarter valued at $32,000. City Holding Co. increased its position in Stryker by 528.6% during the first quarter. City Holding Co. now owns 88 shares of the medical technology company's stock worth $33,000 after buying an additional 74 shares in the last quarter. VSM Wealth Advisory LLC acquired a new position in shares of Stryker in the fourth quarter worth $36,000. Finally, Smallwood Wealth Investment Management LLC purchased a new stake in shares of Stryker in the first quarter valued at $40,000. Institutional investors and hedge funds own 77.09% of the company's stock.

Insiders Place Their Bets

In other news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the sale, the director directly owned 3,417,326 shares of the company's stock, valued at approximately $1,288,195,208.96. This represents a 5.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 5.90% of the stock is owned by corporate insiders.

Analyst Ratings Changes

SYK has been the subject of several recent analyst reports. Wall Street Zen cut Stryker from a "buy" rating to a "hold" rating in a report on Friday, June 27th. BTIG Research restated a "buy" rating on shares of Stryker in a report on Monday. Roth Mkm upped their price target on shares of Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a research report on Friday, May 2nd. Citigroup reiterated a "buy" rating and issued a $455.00 price target (up previously from $443.00) on shares of Stryker in a report on Thursday, May 22nd. Finally, JMP Securities reissued a "market perform" rating on shares of Stryker in a research note on Monday, May 5th. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $428.55.

Stryker Stock Down 0.5%

SYK traded down $1.85 during trading on Thursday, hitting $389.02. The company had a trading volume of 1,039,855 shares, compared to its average volume of 1,352,169. The company has a market capitalization of $148.49 billion, a PE ratio of 52.57, a PEG ratio of 2.95 and a beta of 0.91. The company has a quick ratio of 1.00, a current ratio of 1.64 and a debt-to-equity ratio of 0.69. Stryker Corporation has a one year low of $314.93 and a one year high of $406.19. The firm's 50-day moving average price is $385.38 and its 200 day moving average price is $377.55.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.73 by $0.11. The company had revenue of $5.87 billion for the quarter, compared to analysts' expectations of $5.68 billion. Stryker had a return on equity of 23.74% and a net margin of 12.31%. The business's revenue was up 11.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.50 EPS. As a group, equities analysts expect that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be given a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date is Monday, June 30th. Stryker's dividend payout ratio is currently 45.41%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.